New Weight-Loss Drug Shows Promise in Early Study(Page 3) "I think this class of drugs, should it make it to market, is going to need to be reserved for people who have complications related to their obesity, such as type 2 diabetes, high blood pressure or severe osteoarthritis," Smith said. In general, he added, taranabant would be best for those with a body mass index of 30 or higher (classified as obese), or those with a BMI of 27, considered overweight, but with complications. More information To learn more about obesity, visit the Obesity Society. Related Links
advertisement
| ||
What's HOTGet our free newsletter
PR Newswire |
 |
The drkoop.com URL and web site are not associated with C. Everett Koop, M.D., former Surgeon General of the United States.
By using this service, you accept our Terms of Use. Please read them. The consumer health information on drkoop.com is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2004-2008. The HealthCentral Network, Inc. All rights reserved.